The Evolution Of US FDA Advisory Committee Votes On COVID-19 Vaccines
Executive Summary
From surprisingly contentious to surprisingly unanimous, VRBPAC's favorable votes have grown from 17 to 21 over the course of three meetings on coronavirus vaccines.